Department of Veterinary and Biomedical Sciences, College of Veterinary Medicine, University of Minnesota, Saint Paul, MN 55108, USA.
Department of Animal, Dairy and Veterinary Sciences, College of Agriculture and Applied Sciences, Utah State University, Logan, UT 84322, USA.
Toxins (Basel). 2019 Jan 18;11(1):55. doi: 10.3390/toxins11010055.
The nearly-ubiquitous food and feed-borne mycotoxin aflatoxin B₁ (AFB₁) is carcinogenic and mutagenic, posing a food safety threat to humans and animals. One of the most susceptible animal species known and thus a good model for characterizing toxicological pathways, is the domesticated turkey (DT), a condition likely due, at least in part, to deficient hepatic AFB₁-detoxifying alpha-class glutathione S-transferases (GSTAs). Conversely, wild turkeys (Eastern wild, EW) are relatively resistant to the hepatotoxic, hepatocarcinogenic and immunosuppressive effects of AFB₁ owing to functional gene expression and presence of functional hepatic GSTAs. This study was designed to compare the responses in gene expression in the gastrointestinal tract between DT (susceptible phenotype) and EW (resistant phenotype) following dietary AFB₁ challenge (320 ppb for 14 days); specifically in cecal tonsil which functions in both nutrient absorption and gut immunity. RNAseq and gene expression analysis revealed significant differential gene expression in AFB₁-treated animals compared to control-fed domestic and wild birds and in within-treatment comparisons between bird types. Significantly upregulated expression of the primary hepatic AFB₁-activating P450 () as well as transcriptional changes in tight junction proteins were observed in AFB₁-treated birds. Numerous pro-inflammatory cytokines, and were significantly down regulated by AFB₁ treatment in DT birds and pathway analysis suggested suppression of enteroendocrine cells. Conversely, AFB₁ treatment modified significantly fewer unique genes in EW birds; among these were genes involved in lipid synthesis and metabolism and immune response. This is the first investigation of the effects of AFB₁ on the turkey gastro-intestinal tract. Results suggest that in addition to the hepatic transcriptome, animal resistance to this mycotoxin occurs in organ systems outside the liver, specifically as a refractory gastrointestinal tract.
无处不在的食品和饲料源性真菌毒素黄曲霉毒素 B₁(AFB₁)具有致癌和致突变性,对人类和动物的食品安全构成威胁。众所周知,最易受影响的动物物种之一,也是表征毒理学途径的良好模型,是驯化火鸡(DT),这种情况很可能至少部分归因于肝脏 AFB₁解毒的 α 类谷胱甘肽 S-转移酶(GSTAs)缺乏。相反,由于功能性基因表达和功能性肝脏 GSTAs 的存在,野生火鸡(东部野生火鸡,EW)对 AFB₁的肝毒性、肝癌和免疫抑制作用相对具有抗性。本研究旨在比较 DT(易感表型)和 EW(抗性表型)在经 AFB₁饮食挑战(14 天 320 ppb)后的胃肠道基因表达反应;特别是在盲肠扁桃体中,其功能既在于营养吸收,也在于肠道免疫。RNAseq 和基因表达分析显示,与对照组相比,AFB₁处理的动物的基因表达存在显著差异,并且在鸟类类型之间的治疗内比较中也是如此。在 AFB₁处理的鸟类中观察到主要的肝脏 AFB₁激活 P450 () 的表达显著上调,以及紧密连接蛋白的转录变化。在 DT 鸟类中,大量促炎细胞因子和 被 AFB₁处理显著下调,而途径分析表明肠内分泌细胞受到抑制。相反,AFB₁处理在 EW 鸟类中改变的独特基因数量显著较少;其中包括参与脂质合成和代谢以及免疫反应的基因。这是首次研究 AFB₁对火鸡胃肠道的影响。结果表明,除了肝脏转录组外,动物对这种真菌毒素的抗性还发生在肝脏以外的器官系统中,特别是在抵抗性的胃肠道中。